Last updated: 4 months ago
CTD Holdings, Inc. 8-K Report: Breakthrough in Niemann-Pick Disease Treatment
CTD Holdings, Inc. announces promising preliminary data on Trappsol® Cyclo™ for Niemann-Pick disease type C, showing its ability to cross the blood-brain barrier. Key clinical trial insights.